Recently Featured
Interior of a pharmaceutical manufacturing plant

Lonza Expands U.S. CDMO Network with Merck KGaA Acquisition

November 6, 2026
Lonza plans to significantly expand its U.S. contract development and manufacturing organization (CDMO) footprint by acquiring five sites from Merck KGaA, Darmstadt, Germany. This acquisition will increase Lonza’s U.S. CDMO sites from four to nine and add approximately 1,100 employees, boosting its workforce by nearly 25%. The deal aims to enhance Lonza’s end-to-end development and…
scientist studying brain tumor cells

Multiomic Atlas Reveals Predictable Patterns in Glioblastoma Cells

November 6, 2026
New research from the Wellcome Sanger Institute and collaborators reveals that aggressive glioblastoma (GB) brain tumors follow predictable patterns rather than chaotic randomness. The study, published in Nature, mapped over one million cells across glioblastoma tumors, categorizing cancer cells at various stages of their development. This research challenges previous beliefs about brain tumors and suggests…
Exterior view of the FDA building

Bernie Sanders to Influence FDA Funding Bill

November 6, 2026
Democrats’ recent electoral victory may significantly affect negotiations regarding the funding for the Food and Drug Administration (FDA), particularly through the influence of Senator Bernie Sanders (I-VT). The FDA relies on user fees from pharmaceutical companies to finance its drug review processes. The Prescription User Fee Drug Act must be renewed before its expiration on…
Virtual workshop on drug development

FDA Workshop on Bioequivalence for Topical Generic Drugs

November 5, 2026
This half-day virtual workshop features FDA expert presentations and audience Q&A on bioequivalence (BE) approaches for topical and transdermal generic drug products. The focus on modernizing BE approaches is crucial for enhancing the development of generic drugs in these categories. This workshop may provide valuable insights for manufacturers and developers looking to navigate the complexities…

Ongoing Cases